Page last updated: 2024-10-26

dipyridamole and Cicatrix

dipyridamole has been researched along with Cicatrix in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Cicatrix: The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Requena, L1
FariƱa, C1
Barat, A1
Beller, G1

Reviews

1 review available for dipyridamole and Cicatrix

ArticleYear
Nuclear cardiology: current indications and clinical usefulness.
    Current problems in cardiology, 1985, Volume: 10, Issue:10

    Topics: Angina Pectoris; Angioplasty, Balloon; Cardiology; Cardiomyopathies; Cicatrix; Coronary Artery Bypas

1985

Other Studies

1 other study available for dipyridamole and Cicatrix

ArticleYear
Degos disease in a patient with acquired immunodeficiency syndrome.
    Journal of the American Academy of Dermatology, 1998, Volume: 38, Issue:5 Pt 2

    Topics: Acquired Immunodeficiency Syndrome; Atrophy; Cicatrix; Dipyridamole; Erythema; Homosexuality, Male;

1998